American International Group, Inc. Adma Biologics, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 105,057 shares of ADMA stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,057

Previous 105,959 0.85%

Holding current value

$1.2 Million

Previous $478,000 44.98%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.4 - $6.74 $3,968 - $6,079	-902 Reduced 0.85%	105,057 $693,000
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $2,553 - $3,747	829 Added 0.79%	105,959 $478,000
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $12,970 - $17,232	3,738 Added 3.69%	105,130 $376,000
Q2 2023 Aug 04, 2023	BUY	$3.12 - $4.22 $1,073 - $1,451	344 Added 0.34%	101,392 $374,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $39,536 - $50,832	13,135 Added 14.94%	101,048 $334,000

Q4 2022 Feb 10, 2023	SELL	$2.47 - $3.88 $792 - $1,245	-321 Reduced 0.36%	87,913 $341,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $2,531 - $3,566	1,247 Added 1.43%	88,234 $214,000
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $124,391 - $191,371	86,987 New	86,987 $172,000
Q2 2021 Aug 13, 2021	SELL	$1.51 - $2.07 $58,002 - $79,512	-38,412 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.67 - $2.95 $168 - $297	101 Added 0.26%	38,412 $68,000
Q4 2020 Feb 12, 2021	BUY	$1.8 - $2.56 $4,176 - $5,939	2,320 Added 6.45%	38,311 $75,000
Q3 2020 Nov 04, 2020	SELL	$2.04 - $3.74 $1,670 - $3,063	-819 Reduced 2.22%	35,991 $86,000
Q2 2020 Aug 12, 2020	SELL	$2.42 - $3.29 $11,589 - $15,755	-4,789 Reduced 11.51%	36,810 $108,000
Q1 2020 May 04, 2020	BUY	$1.5 - $4.59 $15,124 - $46,280	10,083 Added 31.99%	41,599 $120,000
Q4 2019 Feb 05, 2020	SELL	$3.89 - $5.15 $1,030 - $1,364	-265 Reduced 0.83%	31,516 $126,000
Q3 2019 Nov 08, 2019	BUY	$3.19 - $5.39 $45,923 - $77,594	14,396 Added 82.81%	31,781 $141,000
Q2 2019 Aug 13, 2019	BUY	$3.52 - $5.24 $17,772 - $26,456	5,049 Added 40.93%	17,385 $67,000
Q1 2019 May 06, 2019	SELL	$2.61 - $4.35 $1,041 - $1,735	-399 Reduced 3.13%	12,336 $47,000
Q4 2018 Feb 13, 2019	SELL	$2.17 - $6.12 $210 - $593	-97 Reduced 0.76%	12,735 $30,000
Q3 2018 Nov 09, 2018	BUY	$4.39 - $6.85 $2,238 - $3,493	510 Added 4.14%	12,832 $80,000
Q2 2018 Aug 08, 2018	BUY	$4.39 - $5.44 $54,093 - $67,031	12,322 New	12,322 $56,000

Others Institutions Holding ADMA

# of Institutions

224

Shares Held

174M

Call Options Held

85.5K

Put Options Held

12.8K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $2.24B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Adma Biologics, Inc. Transaction History